Mobile
Search
Advanced search
Multi-criteria search
Who are we ?
Log in
Sign up
Français
English
Kusajili – Clinical trials directory
Send this study to a contact
1
Your personal information
Your name
Your e-mail
Send me a copy
2
Your recipient's information
The name of your contact
Your contact email
3
Your message
Votre message
An 8 week, double-blind, randomized, parallel group, active-controlled study to evaluate the efficacy and safety of the combination of Aliskiren /Amlodipine / HCTZ in patients with moderate to severe hypertension https://kusajili.com:443/Trial/LGnF_N9VtEabaGe2BJileg%24an-8-week-double-blind-randomized-parallel-group-active-controlled-study-to-evaluate-the-efficacy-and-safety-of-the-combination
I have read and accept the terms of use of the site and the Privacy Policy
Send your message